Cloud Banner

Healthcare

Image

Global Clinical Chemistry Analyzer Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Clinical Chemistry Analyzer Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 4.8% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 13.50 Billion
Diagram Market Size (Forecast Year) USD 19.64 Billion
Diagram CAGR 4.8%

Global Clinical Chemistry Analyzer Market, By Product (Analyzers, Reagents, Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers, Fully Automated Clinical Chemistry Analyzers), Test Analysis (Basic Metabolic Panel (BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2030.

Clinical Chemistry Analyzer Market

Clinical Chemistry Analyzer Market Analysis and Size

The clinical chemistry analyzers market has seen constant innovation, which has been primarily driven by technological advancement. Ongoing research and development activities, combined with the integration of advanced software technologies in clinical laboratories, will shape the future of clinical chemistry analyzers. Furthermore, stakeholders are likely to develop new products that are in sync with laboratory requirements.                      

Data Bridge Market Research analyses that the clinical chemistry analyzer market which was USD 13.5 billion in 2022, is expected to reach up to USD 19.64 billion by 2030, and is expected to undergo a CAGR of 4.80% during the forecast period. This indicates that the market value. “Reagents” dominates the product segment of the clinical chemistry analyzer market due to the frequent need for reagents in large quantities, as opposed to analyzers. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Clinical Chemistry Analyzer Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Analyzers, Reagents, Calibrators, Controls, Standards, Others, Others) Analyzer Technology (Semi-Automated Clinical Chemistry Analyzers, Fully Automated Clinical Chemistry Analyzers), Test Analysis (Basic Metabolic Panel (BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel) End User Analysis (Hospitals, Academic Research Centers, Diagnostic Laboratories, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott (U.S.), Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Siemens (Germany), ELI Tech Group (France), HORIBA, Ltd.( Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Randox Laboratories Ltd. (U.K.), Ortho Clinical Diagnostics (U.S.), Nova Biomedical (U.S.), Sysmex Corporation (Japan), Bio Systems Diagnostics Pvt. Ltd. (India), DiaSys Diagnostic Systems GmbH (Germany), Endress Hauser Management AG (Switzerland), Diatron (Hungary), SFRI. (France), EKF and Medica Corporation (U.K.), among others

Market Opportunities

  • Launch of innovative and technologically advanced products to meet the needs of customers
  • Increase in the prevalence of chronic diseases
  • Increase in the number of mergers and acquisitions among manufacturers

Market Definition

A clinical chemistry analyzer is a medical laboratory instrument used for analyzing and measuring various chemical components and biomarkers in biological samples, such as blood, urine, and serum. These analyzers play a critical role in diagnosing and monitoring various medical conditions, including assessing organ function, detecting diseases, and monitoring the effectiveness of treatment. They provide quantitative data on parameters such as blood glucose, electrolytes, enzymes, hormones, and more, aiding healthcare professionals in patient care and clinical decision-making. In essence, a clinical chemistry analyzer is a vital tool for conducting comprehensive biochemical analyses in medical diagnostics.            

Clinical Chemistry Analyzer Market Dynamics

Drivers

  • Rising Disease Burden

The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and kidney diseases is driving the demand for clinical chemistry analyzers. These devices are essential for diagnosing and monitoring these conditions, leading to a growing market.

  • Advancements in Technology

Ongoing technological advancements have led to more efficient and automated clinical chemistry analyzers, improving testing accuracy and reducing turnaround times. This, in turn, is attracting healthcare facilities to invest in modern equipment.

  • Growing Aging Population 

The global population is aging, leading to a higher incidence of age-related diseases and conditions that require regular monitoring. Clinical chemistry analyzers are crucial in managing the health of the elderly, further fueling market growth.

  • Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

  • Increasing Demand for Clinical Chemistry Analyzers

There is an increasing demand for clinical chemistry analyzers that can be integrated into point-of-care settings, such as clinics and physician's offices. This enables faster results and better patient care, presenting an opportunity for analyzer manufacturers to expand their reach.

  • Emerging Markets

Emerging economies are witnessing a growing middle-class population with higher healthcare expectations. This presents an opportunity for clinical chemistry analyzer manufacturers to tap into these markets by offering cost-effective and scalable solutions.

Restraints/ Challenges

  • High Initial Costs

Clinical chemistry analyzers are sophisticated and specialized instruments. Their high initial acquisition cost, installation costs, and ongoing maintenance expenses can be a significant burden, especially for smaller healthcare facilities, clinics, and laboratories with limited budgets. This financial barrier may deter some potential buyers from investing in this equipment, limiting market growth.

  • Stringent Regulatory Requirements

Clinical chemistry analyzers are used in medical diagnostics, and as such, they must meet rigorous regulatory and quality standards to ensure the accuracy and safety of test results. Complying with these standards requires extensive testing, documentation, and quality control processes. Meeting these regulatory requirements can be time-consuming and expensive for manufacturers, leading to delays in product development and market entry.

  • Limited Reimbursement Policies

The availability and terms of reimbursement for clinical chemistry tests can vary by region and healthcare system. In some areas, reimbursement policies for certain tests may be limited or subject to frequent changes. This uncertainty can be a concern for healthcare facilities, as they may invest in clinical chemistry analyzers but struggle to secure adequate reimbursement for the tests they perform. This can impact the financial viability of using clinical chemistry analyzers, making healthcare providers more cautious about adopting these systems.

  • Sample Contamination and Errors

The accuracy of clinical chemistry tests heavily depends on the quality and proper handling of biological samples, such as blood or urine. Contamination or errors in the collection, storage, or transportation of samples can significantly affect the results. Ensuring the integrity of samples throughout the testing process is a continuous challenge, particularly in busy healthcare settings with high sample volumes.

This clinical chemistry analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability
  • In April 2022, Sysmex Europe launched its new three-part differential system, the XQ-320 XQ-Series Automated Hematology Analyzer. With reliable technology and a new level of usability, the XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments

Global Clinical Chemistry Analyzer Market Scope

The clinical chemistry analyzer market is segmented on the basis of product, analyzer technology, test analysis and end user analysis. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Analyzers
  • Reagents
  • Calibrators
  • Controls
  • Standards
  • Others
  • Others

Analyzer Technology

  • Semi-Automated Clinical Chemistry Analyzers
  • Fully Automated Clinical Chemistry Analyzers

 Test Analysis

  • Basic Metabolic Panel(BMP)
  • Liver Panel
  • Electrolyte Panel
  • Renal Profile
  • Lipid Profile
  • Specialty Chemical Tests
  • Thyroid Function Panel

End User Analysis

  • Hospitals
  • Academic Research Centers
  • Diagnostic Laboratories
  • Others

Clinical Chemistry Analyzer Market Regional Analysis/Insights

The clinical chemistry analyzer market is analysed and market size insights and trends are provided by product, analyzer technology, test analysis and end user analysis as referenced above.

The countries covered in the clinical chemistry analyzer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the clinical chemistry analyzer market due to the encouraging initiatives taken by the government and increased application of practice guidelines released by healthcare organizations will further boost the growth of the clinical chemistry analyzer market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the clinical chemistry analyzer market due to the increase in the research and development investment by the global players. Moreover, the occurrence of unmapped opportunities is further anticipated to propel the growth of the clinical chemistry analyzer market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The clinical chemistry analyzer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for clinical chemistry analyzer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the clinical chemistry analyzer market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Clinical Chemistry Analyzer Market Share Analysis

The clinical chemistry analyzer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to clinical chemistry analyzer market.

Some of the major players operating in the clinical chemistry analyzer market are:

  • Abbott (U.S.)
  • Danaher (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Siemens (Germany)
  • ELI Tech Group (France)
  • HORIBA, Ltd. (Japan)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
  • Randox Laboratories Ltd. (U.K.)
  • Ortho Clinical Diagnostics (U.S.)
  • Nova Biomedical (U.S.)
  • Sysmex Corporation (Japan)
  • Bio Systems Diagnostics Pvt. Ltd. (India)
  • DiaSys Diagnostic Systems GmbH (Germany)
  • Endress Hauser Management AG (Switzerland)
  • Diatron (Hungary)
  • SFRI. (France)
  • EKF Medica Corporation (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The clinical chemistry analyzer market size will be worth USD 19.64 billion by 2030 during the forecast period.
The growth rate of the clinical chemistry analyzer market is 4.80% in the forecast period by 2030.
The increasing prevalence of chronic diseases, ongoing technological advancements & growing aging population are the growth drivers of the clinical chemistry analyzer market.
The Product, analyzer technology, test analysis, and end-user analysis are the factors on which the clinical chemistry analyzer market research is based.
The Major companies in the clinical chemistry analyzer market are Abbott (U.S.), Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Siemens (Germany), ELI Tech Group (France), HORIBA, Ltd.( Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Randox Laboratories Ltd. (U.K.), Ortho Clinical Diagnostics (U.S.), Nova Biomedical (U.S.), Sysmex Corporation (Japan), Bio Systems Diagnostics Pvt. Ltd. (India), DiaSys Diagnostic Systems GmbH (Germany), Endress Hauser Management AG (Switzerland), Diatron (Hungary), SFRI. (France), EKF and Medica Corporation (U.K.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials